Cargando…
Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
Background: Use of antipsychotic medication is central in the treatment of psychotic disorders. However, there is limited knowledge about prescription practice of antipsychotics in the critical early phase of these disorders. Clinical guidelines recommend low dosages, but no discontinuation of antip...
Autores principales: | Ringen, Petter Andreas, Reponen, Elina Johanna, Vedal, Trude Seselie Jahr, Andreassen, Ola A., Steen, Nils Eiel, Melle, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747902/ https://www.ncbi.nlm.nih.gov/pubmed/31551838 http://dx.doi.org/10.3389/fpsyt.2019.00649 |
Ejemplares similares
-
Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
por: Gjerde, Priyanthi B., et al.
Publicado: (2022) -
Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021) -
S96. CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Rødevand, Linn, et al.
Publicado: (2018) -
Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
por: Reponen, Elina J., et al.
Publicado: (2020) -
Childhood Trauma Is Nominally Associated With Elevated Cortisol Metabolism in Severe Mental Disorder
por: Aas, Monica, et al.
Publicado: (2020)